Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burwick

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Blood Advances|September 1, 2021
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myelomaLuciano J Costa, Faith E Davies, Gregory P Monohan, et al.
Blood|March 5, 2008
Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
European Journal of Haematology|March 12, 2008
Clinical relevance of soluble HLA class I molecules in Waldenstrom MacroglobulinemiaAnne-Sophie Moreau, Yasmine Sebti, Alain Duhamel, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 6, 2022
Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case seriesRichard M Burwick, Gabriela Dellapiana, Rachel A Newman, et al.
Blood|March 13, 2008
Targeting NF-kappaB in Waldenstrom macroglobulinemiaXavier Leleu, Jérôme Eeckhoute, Xiaoying Jia, et al.
Blood|January 14, 2009
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapyAbdel Kareem Azab, Judith M Runnels, Costas Pitsillides, et al.
Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.
Neurology|May 10, 2006
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answersR M Burwick, P P Ramsay, J L Haines, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2020
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019Richard M Burwick, Sigal Yawetz, Kathryn E Stephenson, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Blood Advances|September 1, 2021
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myelomaLuciano J Costa, Faith E Davies, Gregory P Monohan, et al.
Blood|March 5, 2008
Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
European Journal of Haematology|March 12, 2008
Clinical relevance of soluble HLA class I molecules in Waldenstrom MacroglobulinemiaAnne-Sophie Moreau, Yasmine Sebti, Alain Duhamel, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 6, 2022
Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case seriesRichard M Burwick, Gabriela Dellapiana, Rachel A Newman, et al.
Blood|March 13, 2008
Targeting NF-kappaB in Waldenstrom macroglobulinemiaXavier Leleu, Jérôme Eeckhoute, Xiaoying Jia, et al.
Blood|January 14, 2009
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapyAbdel Kareem Azab, Judith M Runnels, Costas Pitsillides, et al.
Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.
Neurology|May 10, 2006
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answersR M Burwick, P P Ramsay, J L Haines, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2020
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019Richard M Burwick, Sigal Yawetz, Kathryn E Stephenson, et al.
Pageof 15